Skip to main content

HUSSMAN STRATEGIC ADVISORS, INC.

Position in PAHC — Phibro Animal Health Corp

CIK 1179475 ELLICOTT CITY, MD

Position in PAHC

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,318,800
-$1,004,220 QoQ
Shares Held
42,000
0.0% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#60
of 207 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PAHC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

HUSSMAN STRATEGIC ADVISORS, INC. holds $14,720,685 across 7 Drug Manufacturers - Specialty & Generic names. PAHC ranks #5 (9.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 PAHC
Phibro Animal Health Corp
This page
42,000 $1,318,800

All Filings in PAHC

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,318,800 42,000
2026-03-31 $2,323,020 42,000
2025-12-31 $1,569,120 42,000
2025-09-30 $1,699,320 42,000
2025-06-30 $2,145,360 84,000
2025-03-31 $2,691,360 126,000
2024-12-31 $2,205,000 105,000
2023-03-31 $398,320 26,000
2022-12-31 $348,660 26,000
2022-09-30 $345,540 26,000
2022-06-30 $497,380 26,000
2022-03-31 $518,700 26,000
2021-12-31 $530,920 26,000